https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Receives-CHMP-Positive-Opinion-To-Expand-Use-Of-BLINCYTO-Blinatumomab-In-Patients-With-M-27619605/?utm_source=telegram&utm_medium=social&utm_campaign=share